Bolt Biotherapeutics, Inc. reports

Location
900 Chesapeake Drive, Redwood City, CA
State of incorporation
Delaware
Fiscal year end
December 31
Data updated at
9/7/2024, 01:25 AM
Form type Sec Links Description Filing date Reporting date
8-K Report | Data 8-K Sep 4, 2024 Aug 28, 2024
10-Q Report | Data 10-Q Aug 13, 2024 Jun 30, 2024
8-K Report | Data 8-K Aug 13, 2024 Aug 13, 2024
8-K Report | Data 8-K Jul 3, 2024 Jul 2, 2024
8-K Report | Data 8-K Jun 14, 2024 Jun 12, 2024
10-Q Report | Data 10-Q May 14, 2024 Mar 31, 2024
8-K Report | Data 8-K May 14, 2024 May 13, 2024
10-K Report | Data 10-K Mar 21, 2024 Dec 31, 2023
8-K Report | Data 8-K Mar 21, 2024 Mar 21, 2024
SC 13G/A Report SC 13G/A Feb 14, 2024
SC 13G/A Report AMENDMENT NO.1 Feb 14, 2024
SC 13G/A Report AMENDMENT NO. 1 TO SCHEDULE 13G Feb 13, 2024
SC 13D/A Report SC 13D/A Feb 12, 2024
10-Q Report | Data 10-Q Nov 9, 2023 Sep 30, 2023
8-K Report | Data 8-K Nov 9, 2023 Nov 9, 2023
10-Q Report | Data 10-Q Aug 7, 2023 Jun 30, 2023
8-K Report | Data 8-K Aug 7, 2023 Aug 7, 2023
8-K Report | Data 8-K Jun 13, 2023 Jun 12, 2023
10-Q Report | Data 10-Q May 11, 2023 Mar 31, 2023
8-K Report | Data 8-K May 11, 2023 May 11, 2023
SC 13G Report Apr 20, 2023
10-K Report | Data 10-K Mar 29, 2023 Dec 31, 2022
8-K Report | Data 8-K Mar 29, 2023 Mar 29, 2023
SC 13G/A Report SC 13G/A Feb 14, 2023
SC 13G/A Report Feb 13, 2023
SC 13D/A Report SC 13D/A Jan 4, 2023
SC 13D/A Report SC 13D/A Dec 28, 2022
8-K Report | Data 8-K Dec 14, 2022 Dec 14, 2022
10-Q Report | Data 10-Q Nov 10, 2022 Sep 30, 2022
8-K Report | Data 8-K Nov 10, 2022 Nov 10, 2022
SC 13D/A Report SC 13D/A Sep 30, 2022
10-Q Report | Data 10-Q Aug 10, 2022 Jun 30, 2022
8-K Report | Data 8-K Aug 10, 2022 Aug 10, 2022
SC 13D/A Report SC 13D/A Jul 15, 2022
8-K Report | Data 8-K Jun 10, 2022 Jun 10, 2022
SC 13G/A Report SC 13G/A May 16, 2022
10-Q Report | Data 10-Q May 12, 2022 Mar 31, 2022
8-K Report | Data 8-K May 12, 2022 May 12, 2022
10-K Report | Data 10-K Mar 30, 2022 Dec 31, 2021
8-K Report | Data 8-K Mar 30, 2022 Mar 30, 2022
8-K Report | Data 8-K Mar 4, 2022 Mar 1, 2022
SC 13G/A Report BOLT BIOTHERAPEUTICS, INC. Feb 14, 2022
8-K Report | Data 8-K EIRGENIX AMENDMENT Jan 25, 2022 Jan 25, 2022
8-K Report | Data 8-K NEW DIRECTOR ONETTO Dec 16, 2021 Dec 13, 2021
8-K Report | Data 8-K BDC-1001 INTERIM DATA Dec 6, 2021 Dec 6, 2021
SC 13G Report Nov 29, 2021
SC 13D/A Report SC 13D/A Nov 22, 2021
8-K Report | Data 8-K DIRECTOR APPOINTMENT Nov 19, 2021 Nov 15, 2021
10-Q Report | Data Q3 2021 10-Q Nov 9, 2021 Sep 30, 2021
8-K Report | Data 8-K Q3'21 ER Nov 9, 2021 Nov 9, 2021
SC 13D/A Report SC 13D/A Aug 13, 2021
10-Q Report | Data Q2'21 10-Q Aug 12, 2021 Jun 30, 2021
8-K Report | Data Q2'21 EPR 8-K Aug 12, 2021 Aug 12, 2021
8-K Report | Data GENMAB AGREEMENT PRESS RELEASE 8-K Jun 2, 2021 Jun 2, 2021
10-Q Report | Data 10-Q May 13, 2021 Mar 31, 2021
8-K Report | Data 8-K May 13, 2021 May 13, 2021
SC 13G Report SC 13G Apr 7, 2021
8-K Report 8-K Mar 31, 2021 Mar 31, 2021
10-K Report 10-K Mar 31, 2021 Dec 31, 2020
SC 13G Report SC 13G Feb 19, 2021
SC 13G Report SCHEDULE 13G Feb 18, 2021
SC 13D Report SC 13D Feb 17, 2021
SC 13D Report SC 13D Feb 16, 2021
SC 13D Report SC 13D Feb 11, 2021
8-K Report 8-K Feb 9, 2021 Feb 9, 2021